Want to join the conversation?
$BIIB said that the Committee of Medicinal Products for Human Use (CHMP) of the European Medicines Agency recommended the approval of its Tysabri product. The opinion of the CHMP is now referred to the European Commission for final decision on approval. Tysabri is a therapy for the treatment of patients with relapsing forms of multiple sclerosis.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)
$AGIO plunge 15%.. what's happening... is this going for a toss !
Does anyone feel $SBUX CEO Schultz stepping down could prove a disaster for the company?
$DB is going to cut off services for about 3,400 clients in equities trading.